Compounds > ruthenium
Page last updated: 2024-08-22

ruthenium and Parkinson Disease

ruthenium has been researched along with Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cao, K; Dai, Y; Hou, Z; Hu, H; Huang, G; Liu, M; Liu, Y; Mei, J; Sadler, PJ; Wang, Y; Yang, Y; Yuan, S; Zhu, Y1
Becker, S; Camacho-Zarco, AR; Fernandez, CO; Fonseca-Ornelas, L; Schmidt, C; Zweckstetter, M1

Other Studies

2 other study(ies) available for ruthenium and Parkinson Disease

ArticleYear
α-Synuclein as a Target for Metallo-Anti-Neurodegenerative Agents.
    Angewandte Chemie (International ed. in English), 2023, 01-02, Volume: 62, Issue:1

    Topics: alpha-Synuclein; Animals; Organometallic Compounds; Parkinson Disease; Rats; Ruthenium

2023
Small-Molecule-Induced Soluble Oligomers of α-Synuclein with Helical Structure.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2017, Sep-21, Volume: 23, Issue:53

    Topics: alpha-Synuclein; Amino Acid Sequence; Coordination Complexes; Cross-Linking Reagents; Mass Spectrometry; Parkinson Disease; Protein Binding; Protein Folding; Protein Multimerization; Ruthenium; Solubility

2017